We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACN icon
26
Accenture
ACN
$106B
$163M 0.64%
845,728
+80,979
+11% +$15.7M
PFE icon
27
Pfizer
PFE
$143B
$149M 0.59%
4,362,217
-933,696
-18% -$34M
TSM icon
28
TSMC
TSM
$1.94T
$142M 0.56%
3,049,444
+422,236
+16% +$18M
MCD icon
29
McDonald's
MCD
$193B
$137M 0.54%
638,907
+10,584
+2% +$2.27M
CVX icon
30
Chevron
CVX
$382B
$136M 0.54%
1,149,293
+77,799
+7% +$9.45M
TXN icon
31
Texas Instruments
TXN
$248B
$136M 0.54%
1,049,916
+49,101
+5% +$6.05M
BA icon
32
Boeing
BA
$169B
$134M 0.53%
352,451
+4,299
+1% +$1.54M
KO icon
33
Coca-Cola
KO
$383B
$132M 0.52%
2,432,768
+111,632
+5% +$5.98M
TMO icon
34
Thermo Fisher Scientific
TMO
$214B
$125M 0.5%
430,158
+7,613
+2% +$2.18M
ABT icon
35
Abbott
ABT
$187B
$114M 0.45%
1,362,398
+57,356
+4% +$4.87M
HON icon
36
Honeywell
HON
$76.4B
$114M 0.45%
713,364
+8,599
+1% +$1.37M
ORCL icon
37
Oracle
ORCL
$339B
$113M 0.45%
2,059,569
-7,480
-0.4% -$413K
NKE icon
38
Nike
NKE
$64.1B
$113M 0.45%
1,200,735
+45,012
+4% +$3.86M
COST icon
39
Costco
COST
$432B
$112M 0.44%
388,509
+31,250
+9% +$8.79M
C icon
40
Citigroup
C
$213B
$108M 0.43%
1,564,400
+1,014
+0.1% +$69K
NVS icon
41
Novartis
NVS
$302B
$107M 0.42%
1,235,290
+49,902
+4% +$4.48M
UNP icon
42
Union Pacific
UNP
$174B
$103M 0.41%
637,725
+5,459
+0.9% +$918K
ADBE icon
43
Adobe
ADBE
$105B
$100M 0.4%
362,054
+10,756
+3% +$3.14M
DHR icon
44
Danaher
DHR
$138B
$97M 0.38%
757,922
+32,019
+4% +$4.01M
WFC icon
45
Wells Fargo
WFC
$254B
$96.1M 0.38%
1,904,831
+222,502
+13% +$10.5M
AMGN icon
46
Amgen
AMGN
$209B
$95.4M 0.38%
492,867
+61,925
+14% +$11.9M
TJX icon
47
TJX Companies
TJX
$179B
$94.4M 0.37%
1,693,075
-81,760
-5% -$4.45M
SBUX icon
48
Starbucks
SBUX
$119B
$89.9M 0.36%
1,017,199
+95,123
+10% +$8.82M
XOM icon
49
ExxonMobil
XOM
$650B
$85.1M 0.34%
1,205,702
-220,886
-15% -$16M
TM icon
50
Toyota
TM
$228B
$84M 0.33%
624,673
+32,753
+6% +$4.29M
1
2
3 4 5

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.